Scarica l'app Stockscreener
5.48
4.36%
-0.25
Pre-mercato:
5.58
0.10
+1.82%
Precedente Chiudi:
$5.73
Aprire:
$5.73
Volume 24 ore:
68,828
Relative Volume:
0.79
Capitalizzazione di mercato:
$64.55M
Reddito:
$200.00K
Utile/perdita netta:
$-26.17M
Rapporto P/E:
-2.1096
EPS:
-2.5976
Flusso di cassa netto:
$-18.63M
1 W Prestazione:
-16.59%
1M Prestazione:
+10.48%
6M Prestazione:
-6.72%
1 anno Prestazione:
+58.38%
Intervallo 1D:
$5.30
$5.955
Intervallo di 1 settimana:
$5.21
$6.74
Portata 52W:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Nome
Clene Inc
Settore
Industria
Telefono
801-676-9695
Indirizzo
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.48 | 64.55M | 200.00K | -26.17M | -18.63M | -2.5976 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-10-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-07-18 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-02 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-28 | Iniziato | Oppenheimer | Outperform |
Clene Inc Borsa (CLNN) Ultime notizie
Risk Analysis: Can Clene Inc reach resistance levels soon2026 Winners & Losers & High Accuracy Investment Signals - baoquankhu1.vn
Aug Big Picture: Will Clene Inc benefit from AI trendsGlobal Markets & Growth Focused Entry Reports - baoquankhu1.vn
Symbiosis II LLC plans resale of CLNN (NASDAQ: CLNN) — 477,000 shares - Stock Titan
If You Invested $1,000 in Clene (CLNN) - Stock Titan
Whale Trades: Will Clene Inc Equity Warrant outperform during market rallies2026 Key Lessons & Fast Momentum Entry Tips - baoquankhu1.vn
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Hengan International Group Co (OtherHEGIF) and Clene (CLNN) - The Globe and Mail
Highs Report: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAR - baoquankhu1.vn
Clene Secures Third-Year NIH Subaward for ALS Program - The Globe and Mail
Treasury Yields: Is Clene Inc Equity Warrant stock undervalued right nowPrice Action & Reliable Breakout Forecasts - baoquankhu1.vn
Nanotechnology Stocks To Watch TodayMarch 17th - MarketBeat
Clene Inc. Announces NIH Subaward Agreement for ALS Expanded Access Protocol – SEC Filing Details - Minichart
Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook - Minichart
Clene 10-K: Revenue $0.2M, EPS $(2.65) — Net Loss $(26.17)M - TradingView
Clene (NASDAQ: CLNN) pushes CNM-Au8 toward accelerated ALS approval - Stock Titan
Clene Inc. (NASDAQ: CLNN) secures $8M Year 3 ALS grant funding - Stock Titan
Clene (CLNN) Projected to Post Earnings on Monday - MarketBeat
Q1 Earnings Estimate for Clene Issued By HC Wainwright - MarketBeat
Best Nanotechnology Stocks To ResearchMarch 15th - MarketBeat
Promising Nanotechnology Stocks Worth WatchingMarch 14th - MarketBeat
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and American Public Education (APEI) - The Globe and Mail
Clene Inc. (NASDAQ:CLNN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Fear: Is Clene Inc a play on infrastructure spendingTrade Signal Summary & Precise Buy Zone Identification - baoquankhu1.vn
Clene (NASDAQ:CLNN) Receives Buy Rating from Canaccord Genuity Group - MarketBeat
CLNN: Canaccord Genuity Reaffirms Buy Rating with $48 Target | C - GuruFocus
Clene (NASDAQ:CLNN) Issues Earnings Results - MarketBeat
Clene (CLNN) Analyst Rating Maintained at "Buy" with $23 Target - GuruFocus
Clene (NASDAQ:CLNN) Receives Buy Rating from D. Boral Capital - MarketBeat
Clene Nanomedicine "CNM-Au8" Market size expansion of Several Folds by 2034 - openPR.com
Clene Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Clene (CLNN) Reports FY25 Revenue Beat and Prepares for Key FDA Meeting - GuruFocus
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights - Investing News Network
Biopharmaceutical company Clene Inc (CLNN) recently unveiled its new financing strategy—two potential additional financings totaling over $22 millions have completed structural design. This funding plan will enable the company’s operational cash flow to la - Bitget
Clene reports full-year 2025 results: $200k revenue, $26.2M net loss - TradingView
Clene (NASDAQ: CLNN) narrows 2025 loss and readies accelerated ALS NDA filing - Stock Titan
ALS drug CNM-Au8 links biomarker declines to survival, Clene plans FDA filing - Stock Titan
Top Nanotechnology Stocks To Keep An Eye OnMarch 11th - MarketBeat
Clene Inc. (CLNN) Reports Q3 Loss, Lags Revenue Estimates - MSN
Nanotechnology Stocks To ConsiderMarch 10th - MarketBeat
Aug Selloffs: What are the analyst revisions for INCYIs Clene Inc. stock a good investment in YEARNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Nanotechnology Stocks To Follow NowMarch 7th - MarketBeat
Aug Movers: Should I set a stop loss on Clene IncExit Point & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Top Nanotechnology Stocks To ResearchMarch 6th - MarketBeat
Institution Moves: How do insiders feel about Clene IncQuarterly Risk Review & Capital Efficient Trading Techniques - baoquankhu1.vn
Nanotechnology Stocks To Follow TodayMarch 5th - MarketBeat
Best Nanotechnology Stocks Worth Watching – March 3rd - Defense World
CLNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Promising Nanotechnology Stocks To Follow Today – March 2nd - Defense World
Investor Mood: Is Clene Inc Equity Warrant stock undervalued right nowPortfolio Performance Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingMarch 3rd - MarketBeat
Top Nanotechnology Stocks To Consider – March 1st - Defense World
Promising Nanotechnology Stocks To Follow TodayMarch 2nd - MarketBeat
Clene Inc Azioni (CLNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clene Inc Azioni (CLNN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ugwumba Chidozie | 10% Owner |
Feb 03 '26 |
Sale |
4.10 |
5,559 |
22,792 |
550,000 |
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):